SCOPUS 정보 검색 플랫폼

Volumn , Issue 31, 2006, Pages 3296-3298

Skeletal diversity construction via a branching synthetic strategy

(9) Wyatt, Emma E a Fergus, Suzanne a Galloway, Warren R J D a Bender, Andreas a Fox, David J a Plowright, Alleyn T b Jessiman, Alan S c Welch, Martin a Spring, David R a

a UNIVERSITY OF CAMBRIDGE (United Kingdom)

b ASTRAZENECA (United Kingdom)

c PFIZER GLOBAL RESEARCH AND DEVELOPMENT (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID DERIVATIVE; ANTICOAGULANT AGENT; COUMARIN DERIVATIVE; GENE PRODUCT; NATURAL PRODUCT; PYRIMIDINONE DERIVATIVE; WARFARIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PROTEIN SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; SOLID PHASE EXTRACTION; STRUCTURE ACTIVITY RELATION;

EID: 33746720909 PISSN: 13597345 EISSN: None Source Type: Journal
DOI: 10.1039/b607710b Document Type: Article

Times cited : (92)

References (37)

1
- 0037416141
- S. L. Schreiber Chem. Eng. News 2003 81 51 61
- (2003) Chem. Eng. News , vol.81 , pp. 51-61
- Schreiber, S.L.¹

2
- 21144440283
- and references therein
- D. R. Spring Chem. Soc. Rev. 2005 34 472 482
- (2005) Chem. Soc. Rev. , vol.34 , pp. 472-482
- Spring, D.R.¹

3
- 0037119336
- R. Breinbauer I. R. Vetter H. Waldmann Angew. Chem., Int. Ed. 2002 41 2878 2890
- (2002) Angew. Chem., Int. Ed. , vol.41 , pp. 2878-2890
- Breinbauer, R.¹ Vetter, I.R.² Waldmann, H.³

4
- 11144311139
- J. Clardy C. Walsh Nature 2004 432 829 837
- (2004) Nature , vol.432 , pp. 829-837
- Clardy, J.¹ Walsh, C.²

5
- 0034678033
- S. L. Schreiber Science 2000 287 1964 1969
- (2000) Science , vol.287 , pp. 1964-1969
- Schreiber, S.L.¹

6
- 0344515366
- D. R. Spring Org. Biomol. Chem. 2003 1 3867 3870
- (2003) Org. Biomol. Chem. , vol.1 , pp. 3867-3870
- Spring, D.R.¹

7
- 3042799070
- M. D. Burke S. L. Schreiber Angew. Chem., Int. Ed. 2004 43 46 58
- (2004) Angew. Chem., Int. Ed. , vol.43 , pp. 46-58
- Burke, M.D.¹ Schreiber, S.L.²

8
- 33644839988
- D. S. Tan Nat. Chem. Biol. 2005 1 74 84
- (2005) Nat. Chem. Biol. , vol.1 , pp. 74-84
- Tan, D.S.¹

9
- 14144251136
- For recent exemplars:
- P. Arya R. Joseph Z. Gan B. Rakic Chem. Biol. 2005 12 163 180
- (2005) Chem. Biol. , vol.12 , pp. 163-180
- Arya, P.¹ Joseph, R.² Gan, Z.³ Rakic, B.⁴

10
- 14844300078
- Z. Gan P. T. Reddy S. Quevillon S. Couve-Bonnaire P. Arya Angew. Chem., Int. Ed. 2005 44 1366 1368
- (2005) Angew. Chem., Int. Ed. , vol.44 , pp. 1366-1368
- Gan, Z.¹ Reddy, P.T.² Quevillon, S.³ Couve-Bonnaire, S.⁴ Arya, P.⁵

11
- 20944433279
- R. S. Dothager K. S. Putt B. J. Allen B. J. Leslie V. Nesterenko P. J. Hergenrother J. Am. Chem. Soc. 2005 127 8686 8696
- (2005) J. Am. Chem. Soc. , vol.127 , pp. 8686-8696
- Dothager, R.S.¹ Putt, K.S.² Allen, B.J.³ Leslie, B.J.⁴ Nesterenko, V.⁵ Hergenrother, P.J.⁶

12
- 25144448174
- G. D. Geske R. J. Wezeman A. P. Siegel H. E. Blackwell J. Am. Chem. Soc. 2005 127 12762 12763
- (2005) J. Am. Chem. Soc. , vol.127 , pp. 12762-12763
- Geske, G.D.¹ Wezeman, R.J.² Siegel, A.P.³ Blackwell, H.E.⁴

13
- 23844515192
- B. Clique J. Colley A. Ironmonger A. Nelson P. Stockley J. Titchmarsh B. Whittaker Org. Biomol. Chem. 2005 3 2776 2785
- (2005) Org. Biomol. Chem. , vol.3 , pp. 2776-2785
- Clique, B.¹ Colley, J.² Ironmonger, A.³ Nelson, A.⁴ Stockley, P.⁵ Titchmarsh, J.⁶ Whittaker, B.⁷

14
- 33746927183
- DOI: 10.1039/b602822e
- T. Leßmann H. Waldmann Chem. Commun. 2006
- (2006) Chem. Commun.
- Leßmann, T.¹ Waldmann, H.²

15
- 0142147275
- M. D. Burke S. L. Schreiber Science 2003 302 613 618
- (2003) Science , vol.302 , pp. 613-618
- Burke, M.D.¹ Schreiber, S.L.²

16
- 4544326369
- S. J. Taylor A. M. Taylor S. L. Schreiber Angew. Chem., Int. Ed. 2004 43 1681 1685
- (2004) Angew. Chem., Int. Ed. , vol.43 , pp. 1681-1685
- Taylor, S.J.¹ Taylor, A.M.² Schreiber, S.L.³

17
- 12344293904
- H. Oguri S. L. Schreiber Org. Lett. 2005 7 47 50
- (2005) Org. Lett. , vol.7 , pp. 47-50
- Oguri, H.¹ Schreiber, S.L.²

18
- 29844455070
- N. Kumar M. Kiuchi J. A. Tallarico S. L. Schreiber Org. Lett. 2005 7 2535 2538
- (2005) Org. Lett. , vol.7 , pp. 2535-2538
- Kumar, N.¹ Kiuchi, M.² Tallarico, J.A.³ Schreiber, S.L.⁴

19
- 28044432353
- C. T. Calderone D. R. Liu Angew. Chem., Int. Ed. 2005 44 7383 7386
- (2005) Angew. Chem., Int. Ed. , vol.44 , pp. 7383-7386
- Calderone, C.T.¹ Liu, D.R.²

20
- 33744475697
- J. M. Mitchell J. T. Shaw Angew. Chem., Int. Ed. 2006 45 1722 1726
- (2006) Angew. Chem., Int. Ed. , vol.45 , pp. 1722-1726
- Mitchell, J.M.¹ Shaw, J.T.²

21
- 33746272686
- N. Kumagai G. Muncipinto S. L. Schreiber Angew. Chem., Int. Ed. 2006 45 3635 3638
- (2006) Angew. Chem., Int. Ed. , vol.45 , pp. 3635-3638
- Kumagai, N.¹ Muncipinto, G.² Schreiber, S.L.³

22
- 0003438149
- Wiley, Chichester,. It should be emphasized that acetyl coenzyme A and the fluorous tagged diazoacetate are used in different ways synthetically: the diazoacetate is only used once, whereas acetyl CoA is used iteratively
- P. M. Dewick, Medicinal Natural Products: A Biosynthetic Approach, Wiley, Chichester, 2001
- (2001) Medicinal Natural Products: A Biosynthetic Approach
- Dewick, P.M.¹

23
- 0003394220
- Wiley-Interscience, New York, For reviews see:
- M. P. Doyle, M. A. McKervey and T. Ye, Modern Catalytic Methods for Organic Synthesis with Diazo Compounds, Wiley-Interscience, New York, 1998
- (1998) Modern Catalytic Methods for Organic Synthesis with Diazo Compounds
- Doyle, M.P.¹ McKervey, M.A.² Ye, T.³

24
- 0031029886
- A. Studer S. Haddida R. Ferritto S.-Y. Kim P. Jeger P. Wipf D. P. Curran Science 1997 275 823 826
- (1997) Science , vol.275 , pp. 823-826
- Studer, A.¹ Haddida, S.² Ferritto, R.³ Kim, S.-Y.⁴ Jeger, P.⁵ Wipf, P.⁶ Curran, D.P.⁷

25
- 0348072278
- J. A. Gladysz, D. P. Curran and I. T. Horvath), Wiley-VCH, Weinheim, pp. 101-155
- D. P. Curran, in The Handbook of Fluorous Chemistry (Eds.:, J. A. Gladysz, D. P. Curran and I. T. Horvath, ), Wiley-VCH, Weinheim, 2004, pp. 101-155
- (2004) The Handbook of Fluorous Chemistry
- Curran In, D.P.¹

26
- 2942545969
- W. Zhang Chem. Rev. 2004 104 2531 2556
- (2004) Chem. Rev. , vol.104 , pp. 2531-2556
- Zhang, W.¹

27
- 32144432500
- D. P. Curran Aldrichimica Acta 2006 39 3 9
- (2006) Aldrichimica Acta , vol.39 , pp. 3-9
- Curran, D.P.¹

28
- 85172409774
- E. Büchner T. Curtius Ber. Dtsch. Chem. Ges. 1885 18 2371 2377
- (1885) Ber. Dtsch. Chem. Ges. , vol.18 , pp. 2371-2377
- Büchner, E.¹ Curtius, T.²

29
- 37049107338
- A. J. Anciaux A. Demonceau A. F. Noels N. Petinoit P. Teyssié J. Chem. Soc., Chem. Commun. 1980 765 766
- (1980) J. Chem. Soc., Chem. Commun. , pp. 765-766
- Anciaux, A.J.¹ Demonceau, A.² Noels, A.F.³ Petinoit, N.⁴ Teyssié, P.⁵

30
- 0001432893
- A. J. Anciaux A. Demonceau A. F. Noels A. J. Hubert R. Warin P. Teyssié J. Org. Chem. 1981 46 873 876
- (1981) J. Org. Chem. , vol.46 , pp. 873-876
- Anciaux, A.J.¹ Demonceau, A.² Noels, A.F.³ Hubert, A.J.⁴ Warin, R.⁵ Teyssié, P.⁶

31
- 0025314764
- R. H. Kline J. Wright K. M. Fox M. E. Eldefrawi J. Med. Chem. 1990 33 2024 2027
- (1990) J. Med. Chem. , vol.33 , pp. 2024-2027
- Kline, R.H.¹ Wright, J.² Fox, K.M.³ Eldefrawi, M.E.⁴

32
- 0344392778
- C. V. Galliford M. A. Beenen S. T. Nguyen K. A. Scheidt Org. Lett. 2003 5 3487 3490
- (2003) Org. Lett. , vol.5 , pp. 3487-3490
- Galliford, C.V.¹ Beenen, M.A.² Nguyen, S.T.³ Scheidt, K.A.⁴

33
- 0035945997
- J. J. V. Eynde N. Hecq O. Kataeva C. O. Kappe Tetrahedron 2001 57 1785 1791
- (2001) Tetrahedron , vol.57 , pp. 1785-1791
- Eynde, J.J.V.¹ Hecq, N.² Kataeva, O.³ Kappe, C.O.⁴

34
- 33746669667
- Since the final steps of the synthesis removed the fluorous tag, all compounds were separated from tag using techniques such as fluorous solid-phase extraction (SPE). In approximately 40% of examples the products were not of sufficient purity, and were therefore purified further
- Since the final steps of the synthesis removed the fluorous tag, all compounds were separated from tag using techniques such as fluorous solid-phase extraction (SPE). In approximately 40% of examples the products were not of sufficient purity, and were therefore purified further

35
- 33746769115
- MDL Drug Data Report, Elsevier MDL, http://www.mdli.com

36
- 0037424719
- R. Faghih W. Dwight J. Bao Pan G. B. Fox K. M. Krueger T. A. Esbenshade J. M. McVey K. Marsh Y. L. Bennani A. A. Hancock Bioorg. Med. Chem. Lett. 2003 13 1325 1328
- (2003) Bioorg. Med. Chem. Lett. , vol.13 , pp. 1325-1328
- Faghih, R.¹ Dwight, W.² Bao, P.J.³ Fox, G.B.⁴ Krueger, K.M.⁵ Esbenshade, T.A.⁶ McVey, J.M.⁷ Marsh, K.⁸ Bennani, Y.L.⁹ Hancock, A.A.¹⁰

37
- 33746664976
- Staphylococcus aureus strain MRSA-15 (common pathogenic strain in UK hospitals) were used for inhibition of proliferation phenotypic experiments. Compounds modulated growth over a range of concentrations: 100 μM concentration (29%), 50 μM (6%), 25 μM (4%), 10 μM (2%). The most active compounds were found to have Minimal Inhibitory Concentrations (MIC) of 3.56 and 6.05 μg/ml
- Staphylococcus aureus strain MRSA-15 (common pathogenic strain in UK hospitals) were used for inhibition of proliferation phenotypic experiments. Compounds modulated growth over a range of concentrations: 100 μM concentration (29%), 50 μM (6%), 25 μM (4%), 10 μM (2%). The most active compounds were found to have Minimal Inhibitory Concentrations (MIC) of 3.56 and 6.05 μg/ml

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.